I spent over a decade at the bench before I started a company to build an ELN and LIMS. Academic cancer research first, then cell therapy at a mid-size biotech, then preclinical process development work at a small startup. Along the way I used paper notebooks, shared drives, Excel trackers, and one of the clunkiest LIMS you could ever imagine (from one of the market leaders). So when I write about ELN implementation mistakes, I'm not working from a vendor checklist or a management framework. I'm writing from what I watched happen, in my own labs and in the dozens of labs whose scientists we've talked to over the past almost seven years.
Here's the story that put me on this path: At the startup, one of our scientists left, and a lot of the company's know-how walked out with her. Some of it was in her head. The rest was buried in five paper notebooks that followed a numbering system that I'm sure made perfect sense to her, but without a clue to the underlying logic, to no one else. I went to management with quotes from a handful of ELN and LIMS vendors, arguing we should go digital before we lost anything else. A few of those quotes were close to six figures. For a team of four (2 scientists and 2 managers). Per year. I got laughed out of the room.
My own documentation wasn't great at first either, I just didn't know it at the time. In academia I kept a paper notebook and wrote down the steps, the dilutions, the incubation times. Usually. But lot numbers and catalog numbers for antibodies often didn't make it onto the page. I used the actin antibody from the box in the lab fridge, same as everyone else, so why write it down every time? I didn't note which batch of FBS I'd used, or the centrifugation speed, because we always did it the same way, and nobody wants to write a whole novel at the end of every day. Dilution calculations for setting up an assay got scribbled on the glass shield of the tissue culture hood and wiped off when I was done. We had no inventory system either. If you needed an antibody, you went into the lab and dug through the boxes in the fridge to see if we had one for your target. Same with everything else: you just went and searched the fridges, freezers, and shelves.
I did good work, and I got solid results, if I may say so myself. But years later, even I would struggle to fully reproduce some of it. Not because the science was shaky or the data was ever anything less than clean, but because of the little details I left out of the write-ups. I'd have to do real detective work just to pin down which clone of a given antibody I'd used. And if a colleague had wanted to pick up where I left off, they'd have faced five dense notebooks with no easy way to search them, and no reliable link between a protocol and the data files in some folder tree on the university's server that went with it.
Research generates an enormous amount of information. How the experiment was set up, the dilutions and the calculations, the small observations about whether the cells looked happy or unhappy that morning, the samples and reagents used, the protocols followed, the raw data, the analysis files, the write-ups, the conclusions. When all of that gets tracked by hand, time gets wasted, and, worse, information gets lost, because the next person can't find it or can't piece it back together.
That's the real reason electronic lab notebooks matter. I don't love calling them a game-changer, partly because the term is so overused and partly because it's usually the kind of thing AI writes, but I'm not sure how else to put it. A good one keeps you organized, helps you find things, makes collaboration actually possible, and protects the work so that someone else can build on it after you've gone.
When we planned IGOR, we spent over a year just talking to scientists in academia and industry, mapping the frustrations with existing tools and the day-to-day reality of documentation, with and without software. We saw dozens of "systems" cobbled together out of OneNote, paper logs, and whatever else was to hand. The ingenuity is honestly impressive, especially in scrappy research teams where the enterprise software tools like Benchling or LabWare seem forever out of reach due to the steep pricing and steeper learning curve. We folded all of it, the feedback and the observations and our own experience at the bench, into the plan, and only then started building. We also talked to plenty of companies that had already rolled out an ELN or LIMS, with wildly mixed results.
So the ELN implementation mistakes below aren't hypothetical. They're patterns I've watched teams repeat, across labs at very different stages. And the software is rarely the culprit. The damage usually gets done before anyone logs in, and in the first few weeks after. The good news is that almost all of it is avoidable once you know what to look for. Here are the ten mistakes I see most often.
Why ELN Implementations Go Wrong
Researchers are busy, and "implement a new software system" doesn't make anyone's priority list until there's already a problem. Usually something forces it: a compliance push, or a new hire who's used to digital tools and can't believe you're still on paper. And sometimes it's just a PI who's had enough of digging through the shared Google Drive. Whatever sets it off, the decision tends to happen fast.
In most cases nobody makes a concrete plan for the rollout, the training, the use policy, or even how the workspace should be organized. The team books a two-hour training session with the vendor and assumes that once it's done, everyone will switch over and that's that. It almost never works that way.
What follows is a stretch where the software technically exists, adoption is patchy, and each person is working from a slightly different picture of how it's supposed to be used. That's the failure mode. And it traces back, nearly every time, to the ten decisions below.
Mistake 1: Not Getting Buy-In Before You Buy
This is something that we've seen happen so many times. Someone in management picks the ELN without asking the scientists who will actually use it what they need.
So the wrong things get prioritized. "AI readiness," whatever that means, because surely every team will want it eventually. An integration with finance's accounting system (whatever for). API access that looked impressive in the sales demo, even though nobody on the team knows how to set it up or what they'd do with it. Then the scientist starts using the software at the bench and struggles, because the table sections won't accept a simple import from the Excel file the plate reader spat out, so every value has to be retyped by hand. Or because they logged the wrong sample out of inventory and there's no way to put it back, which means the colleague who needed that sample can't finish their write-up either. And yes, these are some of the real problems we've seen with some of the ELN and LIMS platforms on the market.
The first rule of a rollout that sticks is to involve the people who'll use it. Get a demo, yes, but also get a trial and put real scientists on it. A purchase made by a single admin or IT lead, with no input from the bench, almost always runs aground. A postdoc who's kept paper notebooks for eight years needs a real reason to switch, not a mandate from someone who doesn't work at the bench.
Lack of end-user involvement is one of the most cited reasons lab informatics projects fail. The fix takes time but isn't complicated. Build a cross-functional group from day one: bench scientists, a PI or group leader, the lab manager, QA if you're in a regulated environment, and IT. Get them into the vendor demos together and let them push on the workflows that matter to them. Scientists who helped choose the system are the ones who end up explaining it to everyone else, because they feel some ownership and responsibility over making it work.
Leadership buy-in is a separate thing, and it matters just as much. If the PI treats this as an IT project rather than research infrastructure, it gets deprioritized at the first sign of friction. The business case has to be concrete: less time hunting for old data, cleaner audit trails, and no institutional knowledge walking out the door when someone leaves. In my experience that last point does the most work, because nearly every PI has been burned by a departure and knows exactly what it cost them.
Building a Stakeholder Communication Plan
Keep the group involved after the decision, not just during it. Monthly check-ins cover most teams. A small focus group spanning your different user types, bench scientists, lab managers, QA, a group leader or PI, surfaces the small frustrations while they're still small. People who watch their feedback change something stop resisting and start advocating.
Mistake 2: Underestimating What Data Migration Actually Takes
The instinct is to get all the old data in first, before anyone starts using the system. It feels responsible. In practice it's one of the fastest ways to lose the room.
Migrating years of paper notebooks is a bigger job than almost anyone budgets for, and it's tedious. If the first thing you ask your scientists to do is spend weeks retyping and re-uploading old experiments before they've run a single new one in the system, they'll resent the whole thing before they've felt a single benefit. That's how a good ELN gets a bad reputation on week one.
So flip the order. Go live immediately with everything new. New experiments, new inventory, new samples, all of it goes straight into the system from day one. People get to feel how fast and easy it is right away, which is what actually builds adoption. Then migrate the old paper over time, as capacity allows, and only the parts that genuinely matter: ongoing projects, and any historical data you can realistically see yourself needing to pull again.
When you do migrate, it's worth doing properly. Start with a data inventory. Not what you assume you have, but what you actually have. Check email attachments, shared drives, instrument output folders, personal desktop backups. There's always more data in more places than the official system suggests. Talk to your researchers about how they really document their work and where things actually live.
Then decide what gets migrated, and at what fidelity. Active and ongoing projects get full migration with rich metadata, because that's the data people will actually open. Recent data worth keeping accessible gets migrated with searchable fields. Older archives can usually sit in reference storage, as long as you can pull a record when you need it. Migrating a full decade of paper at high fidelity almost never pays off. Put the effort where the data is still being used. Our guide, How to Migrate Lab Data from Paper to an ELN/LIMS, is worth reading before you commit to a timeline.
Mistake 3: Treating Training as a One-Time Event
One session and a PDF manual is what a lot of labs call training. It's really just a starting point, and it's mostly forgotten within two weeks.
The vendor, however hard they try, doesn't know your team, their habits, or the shape of your workflows. So if your ELN or LIMS is customizable at all, you'll need to sit down with your people and map out what you run, what data you collect, how you want to capture it, which metadata matters, and where you want to standardize. That work is yours to do, and it pays off later.
People learn at different speeds, and they only really absorb the software once they connect it to their own work. Watching a demo of how to create an experiment entry is a world away from creating one for the assay you're actually running next Thursday. So the initial training session is a start, not the finish line. The real learning happens once people are in the system doing their own work, and that's exactly when the questions come up.
Two things make that stretch go smoothly. First, make sure the self-help materials are easy to find. Most vendors provide knowledge-base articles, manuals, and short how-to videos, and the issue is rarely that they don't exist. It's that nobody's shown the team where they live. Point people to them on day one so that when someone gets stuck at 6pm, they can find the answer themselves. Second, schedule a follow-up session with the vendor a few weeks after go-live, once everyone's actually had their hands on it. A live Q&A at that point catches the questions that only surface in real use, and it means nobody's left quietly struggling or feeling like they're the only one who hasn't got the hang of it.
Training also needs to be role-specific. A PI juggling several projects has different needs than a technician logging daily observations. A grad student needs to know what level of documentation is actually expected of them. QA staff need to understand how to read an audit trail. One generic session serves none of them well.
Good habits from day one make a real difference to whether adoption holds. Our guide on how to keep a lab notebook covers the practices that make ELN data genuinely useful: contemporaneous entries, complete metadata, linked reagent lots, rather than just technically present.
Mistake 4: Bolting Compliance On After the Fact
When you're choosing an ELN, it's easy to get pulled toward the price tag or the slickest-looking interface in the demos. Both matter. But compliance deserves the same level of attention, and it should be weighed against where your lab is heading, not only where it stands today.
Say you're planning to file your first IND with the FDA in about two years. The nonclinical safety studies behind that filing will need to be run under GLP, and if you're keeping those records electronically, that puts them squarely under 21 CFR Part 11. That stage arrives faster than it feels like it will, and GMP and GCP requirements follow close behind. An ELN that can't meet Part 11 leaves you no real choice but to replace it, and a platform switch in the middle of IND-enabling work is a costly, badly-timed distraction.
Choosing a Part 11-capable platform up front, and building clean documentation habits now, means the regulated work has somewhere to live when it starts, instead of forcing a switch mid-program.
Part 11 comes down to a handful of concrete controls, and those are the things to check a platform for directly [1]. Electronic signatures that carry the same legal weight as a handwritten one. A complete audit trail, so every change to a record is captured against a user, with a timestamp and, for edits, a reason. Unique user accounts with real authentication, which is what lets you trace any entry back to the person who actually made it. And role-based access, so people can see and do only what their role allows. This is the machinery of data integrity, and a platform either has it built in or it doesn't.
Validation tends to worry early-stage teams more than it needs to at this point. Formal computer system validation, the IQ, OQ, and PQ documentation, belongs to the GMP world, and a young company a couple of years out from its first IND is a long way from needing it. What matters now is choosing a vendor who can support that process when the time does come, so it becomes a task you work through later rather than a reason to switch platforms.
So when you evaluate platforms, put the compliance questions on the table early, right beside the ones about price and usability. Ask whether the vendor is compliant with 21 CFR Part 11, then ask to see it in the product: the audit trail, the e-signature workflow, the access controls, rather than a slide that says it's covered. IGOR's security and compliance page covers what's required across the common frameworks, and the ELN and LIMS glossary helps if your team is still getting up to speed on the terminology.
What Your ELN Actually Needs to Support Compliance
ALCOA+ is the framework to hold your system against. It stands for attributable, legible, contemporaneous, original, and accurate, plus complete, consistent, enduring, and available [2]. In practice, your ELN needs to capture who created or changed a piece of data, when, and what changed. That's the baseline for data integrity, and it's what an auditor will look for.
Access controls need to be role-based and documented. Granular permissions do real work here: a technician can create and edit their own entries but not touch someone else's, a PI can approve entries and delegate review, and a compliance auditor gets read access to everything with no ability to change anything. The reason to restrict certain actions to specific roles is structural, not a matter of trust: whoever witnesses an entry needs the oversight context to stand behind it.
A compliant system also means nothing is ever truly deleted. When a record needs correcting, the change is documented and the original stays intact underneath it. Audit trails and entry locking are what make that happen, and in IGOR's electronic lab notebook digital signatures, witness review, and full audit trails come standard.
Mistake 5: Treating Your Notebook and Your Inventory as Two Separate Problems
Many labs buy an ELN, keep samples and reagents in spreadsheets (or in a second tool that was never meant to talk to the first), and then spend forever manually reconciling which sample went into which experiment.
The pain is in the details, and it repeats daily. Which clone of beta Actin antibody was used in Tuesday's western blot? Which lot of primer went into the PCR, and is there enough left to repeat the run? When your notebook and your inventory can't share that information between them, someone has to carry it across by hand, and hand transcription is exactly where errors slip in [3].
And those details matter. Antibody clones and lots vary, FBS batches vary, a fresh lot of primer can move your Ct values. So when a result comes out looking off, the lot number is one of the first things you'll want to check. If it only ever lived in a spreadsheet that nobody tied to the experiment, you can't.
The fix is to treat them as one problem from the start. When you evaluate platforms, look past whether both features exist and check how well they actually connect. IGOR is built as a single ELN and LIMS rather than a notebook with inventory added on the side, and because the two are tied together, the link runs smoothly both ways. Open a notebook entry and you see exactly which samples and reagent lots went into that experiment. Open a sample and you see every experiment it was ever used in. So you can look at your research from whichever angle the moment calls for: experiment-first, to see everything that fed into a result, or sample-first, to trace where a given reagent or specimen ended up. A system where one tool has been patched onto another rarely gives you that. Our guide on LIMS vs ELN vs SDMS walks through how these systems are meant to fit together, and the lab inventory management page shows what that linkage looks like in practice.
Mistake 6: Forcing Everyone Into One Workflow
Different groups work in genuinely different ways. A synthetic chemistry team, an analytical group, and your R&D team capture different data, follow different protocols, and think about their samples differently. A system that expects all of them to work inside one rigid, identical setup is going to fight at least two of the three.
The trouble usually starts with how the workspace gets configured, and whether you can configure it yourself at all. Some platforms need a vendor or a paid consultant for every change, so adapting the setup to how a team actually works turns into an expensive support ticket and a wait. Others give you a single shared workspace for the whole organization. That sounds tidy, but in practice you end up adding field after field, section after section, trying to cover everyone's needs at once. The workspace gets heavier with each addition, and the individual scientist is left wading through options that have nothing to do with their work just to log one experiment.
What you want is the opposite: enough flexibility that each team or department can shape its own environment to fit its science, without that customization spilling over and cluttering everyone else's. A change one group needs shouldn't make the system messier for the group next door.
This is what IGOR's Team Workspaces are built for. Each team sets up its own environment, its own metadata fields, templates, SOPs, and permissions, and configures all of it directly, with no vendor ticket required. When teams do need to work together, sharing is straightforward: admins can port SOPs and templates between workspaces, inventory repositories can be shared directly so everyone works from the same stock, and users can be added to another team's space as guests or with specific roles to collaborate securely. Each group still gets a setup that fits how it actually runs experiments, and collaboration across the organization stays easy.
Mistake 7: Going Live Without a Real Pilot
Going straight to a full, everyone-at-once deployment is a lot like shipping a product you never tested. Something will go wrong. The only open question is whether it trips up five people or fifty.
A pilot is your chance to find those problems while they're still cheap to fix, but only if it's a real one. Running the system on a handful of simple experiments for a couple of weeks tells you almost nothing. What you want is one research group putting their actual work through the new platform for four to six weeks, on real data, start to finish. That means building their own templates and SOPs, capturing data day to day, uploading the awkward instrument files, linking samples, collaborating across the team, and taking entries all the way through witnessing and sign-off. If you run regulated work, push a regulated workflow through as well. Edge cases are where implementations break, and edge cases only surface when people do their real jobs in the system rather than a tidied-up demo version of them.
Pick the pilot group with some care. The instinct is to start with the simplest, most willing team, but an easy workflow gives you a false green light. You want a group whose work represents your harder cases, complex enough to surface the problems you actually need to find, and with the bandwidth to give the pilot real attention instead of squeezing it in around everything else. A distracted month on a trivial workflow tells you almost nothing.
Before the pilot starts, decide what a successful run looks like. A good bar: by the end, can the group take a full experiment through the system without dropping back to paper or a spreadsheet at any step? Every point where someone reaches for the old way is a signal, either a gap in the configuration or a gap in the training, and both are fixable before the wider rollout.
Capture the feedback specifically, and keep it all in one place. "This is confusing" doesn't help anyone. "When I attach a file at step four of a multi-step template, it doesn't show up in the entry header" does, because someone can reproduce it and fix it. Sort what comes in into three piles: things you can configure your way out of, things that are really training gaps, and genuine bugs for the vendor. Clear the first two before you expand, and get a concrete timeline on the third.
Then hold the line on the go/no-go. Don't widen the rollout until the pilot group would actively choose the new system over their old habits. Those same people, having shaped the setup and hit the problems first, become your in-house experts, the ones everyone else goes to with questions. That's worth more than another training session.
Mistake 8: Ignoring What Happens at the Bench
Documentation and the actual experiment are always competing for the same pair of hands. With gloved hands, a running timer, reagents on ice: there's nowhere in that scene for a laptop. Expecting people to document in real time at a desktop asks them to choose between recording what they're doing and getting on with the experiment, and the experiment wins nearly every time. The notes get written up later, from memory, and they're worse for it.
The realistic goal is simple: shorten the gap between doing the work and capturing it. For many scientists that still starts on paper, jotting readings and observations as they go, then moving them into the notebook soon after while it's all still fresh. A system that makes that step quick and painless is doing its job.
And a companion mobile app can help close the gap even further. IGOR's mobile companion app lets scientists scan documents or capture images right in the lab, like a photo of a gel or a plate, and upload them straight to the notebook entry they belong to. Images are removed from the device when the app closes, so your sensitive research data isn't left sitting on someone's personal phone.
Nothing closes the gap between the digital world and the reality at the bench entirely. But shrink it enough and documentation stops being the chore everyone puts off until the end of the day, then reconstructs from memory.
Mistake 9: Picking a Platform You'll Outgrow in Two Years
What works for ten researchers can strain at forty, and a platform that feels quick with two years of data can slow to a crawl with six. If you're early-stage and growing, weigh each option against where you expect to be in three years, not only where you sit today. The risk runs in both directions: a system that punishes you as you grow, through pricing that balloons or caps on projects and samples, or one so heavyweight that you're paying now for enterprise scale you won't touch for years.
So ask concrete questions. How does pricing move as you add users? Are there seat minimums, or storage and item caps? When a new team joins, can they stand up their own workspace without a paid services engagement? And ask to see how the platform performs at real data volumes, not in a clean demo environment with a handful of sample records.
Support and responsiveness matter just as much as raw capacity, and here bigger isn't automatically better. At a large enterprise vendor, a growing lab can be a small account in a very long queue, waiting days on a ticket while a submission deadline comes and goes. A focused team that actually knows your setup, and that you can reach directly, is often what makes the difference when something needs sorting fast. Ask who you'll really be talking to when you need help, and how often the product genuinely ships improvements, because a platform that's stood still for years will keep billing you while it stagnates.
And look past the sticker price. What actually matters is the number over a few years, once you add annual maintenance, the per-seat cost climbing as the team grows, storage upgrades, and the staff hours it takes to keep it running. That's how a tool for a five-person lab ends up quoted near six figures a year, like the ones that got me laughed out of the room. IGOR lists all of its pricing openly and transparently, with no seat minimums and no long-term contracts. And every plan comes with personal onboarding and support.
The vendors who keep their pricing vague and obscure tend to be the ones with surprises waiting in year two.
Mistake 10: Not Defining What "Success" Looks Like
Without something concrete to measure, you can't really say whether the rollout worked, and you can't fix what's quietly failing or defend the spend when someone asks.
So decide what you're measuring before go-live, while you can still capture a baseline. Adoption at 30, 60, and 90 days. How long people spend hunting for old records, surveyed before and after. Data-entry error rates. Documentation-related compliance findings. Each one gives you something to watch as you go, and, when things are going well, something concrete to show the people who signed off on it.
Then actually hold the reviews, at 3, 6, and 12 months. That's where you find out which features nobody touches because the training never reached them, which workflows are quietly breeding workarounds, and which teams are flying while others are still stuck. A short satisfaction survey at each checkpoint gives you the human signal to sit alongside the numbers.
The ROI case isn't complicated, but you do have to sit down and work it out. Most of an ELN's return comes from time saved on documentation and errors avoided [3], so it's worth putting real numbers to it. Measure nothing, and the rollout lives or dies on whoever speaks up loudest, usually the person who really doesn't want to give up their paper and Excel spreadsheets, not the one quietly saving an hour a day. A handful of honest numbers keeps the verdict tied to what's really happening, and hands you a straight answer when someone up the chain asks whether it paid off.
A Practical ELN Implementation Checklist
If it helps, here's what I'd actually do if I were to implement an ELN or LIMS in my lab today, roughly in order.
Before you buy
- Get the people who'll use it in the room early: bench scientists, a lab manager, QA if you're regulated. The ones who help choose it are the ones who make it work later.
- Write down how your teams really document today, what gets captured and where, so you're configuring around reality rather than the SOP.
- Be honest about where you're heading. If regulated work is on the horizon, make 21 CFR Part 11 support a hard requirement now rather than a future scramble.
- Decide how you'll measure success, and capture a baseline while you still can: time lost finding records, error rates, adoption targets.
Choosing a platform
- Put at least three options through demos that use your workflows, not the vendor's tidy sample data. If you're early-stage, our guide on choosing the best ELN for your biotech startup is a good starting point, and the Benchling alternatives guide is a fair map of what each platform is actually good at.
- Check how the notebook and the inventory connect. Can a sample be pulled into an experiment and stay linked both ways?
- Make sure each team can configure its own workspace without a paid services engagement every time something changes.
- Look past the sticker price to the real cost over a few years, and ask who you'll actually reach when something breaks.
- Talk to references at your stage and in your regulatory environment.
Rolling it out
- Go live with new work first. Every new experiment and sample goes in from day one, so people feel the benefit straight away. Migrate old paper gradually, and only the parts you'll genuinely reach for.
- Run a real pilot: one group, four to six weeks, their actual work start to finish, ideally a harder workflow rather than the easiest one.
- Fold the pilot's feedback in before you widen the rollout, and hold off widening it until that group would choose the new system over their old habits.
- Train in waves, keep the self-help materials easy to find, and book a follow-up session with the vendor a few weeks in, once the real questions have surfaced.
After launch
- Keep a help point staffed for the first month, and send short, task-specific tips through the early weeks.
- Hold proper reviews at 3, 6, and 12 months: what's going unused, what's breeding workarounds, who's thriving and who's stuck.
- Track adoption monthly and move your support to wherever the friction actually is.
- If sample tracking is part of the picture, see our lab inventory management page and the inventory management guide for how to set it up properly.
- If SOP management is part of your rollout, Mastering Standard Operating Procedures in the Lab is worth reading alongside this.
Frequently Asked Questions
How long does an ELN implementation take?
It depends on how complicated your setup is. But for a small to mid-size lab with fairly standard needs, two to six months from picking a vendor to being fully live is realistic. Strip out the heavy configuration and it goes quicker. Add a regulated environment, real validation work, and years of data to migrate, and you're realistically into six to nine months, sometimes more. Honestly, though, the software going live is rarely the slow part. If you're a young lab just starting out, without much data or inventory to bring across, you can move fast: with a system like IGOR, you can have your workspace set up, configured to the way your team works, and be logging your first experiments within a couple of days. What actually stretches a timeline is the data and inventory migration, and the training. So a lot of it comes down to how quickly you can bring the whole team up to speed.
Should you migrate all your historical lab data to a new ELN, or only recent records?
Almost never all of it. Active projects and data from the past year or two might be worth migrating with full metadata so they stay searchable. Older archives can usually sit in reference storage, and migrating a full decade of paper rarely justifies the cost or effort. Be honest about how often records are actually pulled: if the last two to three years cover the vast majority of your team's real queries, that's your migration scope. In fact, many teams don't migrate the old data at all. Migration is slow work, and at the start of a rollout the payoff rarely justifies it. The common alternative is a clean cutover: everything created before a defined switchover date stays in its original paper or legacy-system format, kept in reference storage with a clear index so records can still be found when needed. The effort is better spent cataloging what you hold and where it sits than on re-entering years of finished work into a system nobody is likely to query. Our guide on migrating lab data from paper to an ELN walks through how to decide what's worth migrating.
How much of an ELN implementation budget should go to training and change management?
Gartner recommends putting around 15% of the total implementation budget toward change management and training, and more when the change is a big one. Prosci sees the teams who do this well investing 10 to 15% of the project budget, while in practice many organizations spend under 5 to 10% [4]. Aim for somewhere around 15 to 20%, weighted to the higher end if your rollout is complex or your team is wary of change.
Put it in real terms. On a first-year spend of around $50,000, that's roughly $7,500 to $10,000, and it covers a few specific things: the written materials and quick-reference guides people actually reach for, the hands-on training sessions run for each role, the time to build up two or three super-users per team who become the first stop for questions, and the support and refreshers you'll want in the first months after go-live.
How much you need also depends heavily on the vendor. Many vendors charge extra for onboarding, customization help, and ongoing support and hands-on training, and that adds up quietly. Others, IGOR among them, include personal onboarding and training and customer support in every user license, so a good part of the people-side cost is already covered and there's less to budget on top. Either way, the teams that skimp here almost always pay for it later, in poor adoption that costs far more to fix than the training would have up front.
What should you do if your team resists the new ELN after go-live?
First, ask the team to get specific about what they're actually resisting. "I don't like it" tells you nothing. "The approval workflow adds three days to every sign-off" tells you exactly where to look. So sit down with the two or three loudest voices and really listen. More often than not it's a workflow quirk you can fix with a configuration change, or a gap in the training that one focused session clears up. When the resistance is broad and it sticks around even after you've genuinely tried, that usually points back to something earlier: the people pushing back were never really brought into the decision and the tool that was chosen may not actually be suitable for the needs of your team.
Can you do an ELN roll out in phases?
Yes, and honestly it's usually the smarter way to do it. Start with one research group or department, see what works and what trips them up, then carry those lessons into the next. Just keep the phases short, think weeks to a couple of months, not quarters.
What's the most important factor in a successful ELN implementation?
If I had to pick one thing: get the people who'll actually use it involved in the decision making before you buy. Everything else about the rollout gets easier when the scientists at the bench had a hand in choosing the system, because now they've got a reason to make it work. Flip it around and it's obvious why. A platform can be well configured and well taught and still struggle, if the people using it feel it was dropped on them from above.
This post is general overview content drawn from experience and public sources. It isn't formal compliance, regulatory, or legal advice. For decisions about validation or regulatory requirements specific to your lab, consult a qualified compliance professional.
IGOR is a cloud-based ELN and LIMS platform built by scientists who spent years at the bench. If you're evaluating platforms or planning a rollout, book a personal demo and we'll give you a real look at the product and walk through how IGOR handles the workflows your lab actually runs.
References
- U.S. Food and Drug Administration. "21 CFR Part 11: Electronic Records; Electronic Signatures." ecfr.gov
- U.S. Food and Drug Administration. "Data Integrity and Compliance With Drug CGMP: Questions and Answers, Guidance for Industry" (2018). fda.gov
- Technology Networks. "Electronic Lab Notebooks for Researchers: How ELNs Support Better Data Management and AI Analysis." technologynetworks.com
- Prosci. "How to Budget for Change Management." prosci.com